These effects may be due to the observed interference of sulforaphane with NF-κB activity, an assumption that is underscored by the recent finding that tumor-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signaling (46). Here, NFKB1 is linked to Familial prostate cancer.